Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
FEBS Letters|August 26, 1998
A monoclonal antibody recognizing the activation domain of protein C in its calcium-free conformationA Vincenot, J L Pittet, M Aiach, et al.
Nephron|January 1, 1995
Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndromeM Alhenc-Gelas, J Rossert, C Jacquot, et al.
Proteins|March 29, 2001
Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insightsB O Villoutreix, B Dahlbäck, D Borgel, et al.
The Journal of Biological Chemistry|February 4, 1994
Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibodyQ Wu, V Picard, M Aiach, et al.
Annales De Medecine Interne|January 1, 1986
[Low-molecular weight heparins. Prospects in 1985]M Aiach, J N Fiessinger, J F Vitoux, et al.
Thrombosis and Haemostasis|February 3, 1992
Partial characterization of an autoantibody recognizing the secondary binding site(s) of thrombin in a patient with recurrent spontaneous arterial thrombosisJ M Costa, J N Fiessinger, L Capron, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Resistance to activated protein C: role in venous and arterial thrombosisJ Emmerich, M Alhenc-Gelas, M Aiach, et al.
Thrombosis and Haemostasis|January 23, 1991
Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosisP Toulon, L Moulonguet-Doleris, J M Costa, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1996
[Activated protein C resistance: role in venous and arterial thrombosis]J Emmerich, M Alhenc-Gelas, M Aiach, et al.
FEBS Letters|May 29, 1995
Human thrombin variable region 1, including E39, is involved in interactions with alpha 1-antitrypsin M358R and protein CP Gaussem, V Picard, G Chadeuf, et al.
Pageof 16